Top Pharmaceuticals companies in Switzerland by Price to Book Ratio (P/B)

This ranking features the top 29 Pharmaceuticals companies in Switzerland ranked by Price to Book Ratio (P/B), averaging a Price to Book Ratio (P/B) of 2.08, for January 15, 2025.

Switzerland

Pharmaceuticals

#	Name	Price to Book Ratio (P/B)	Reported Date	Stock Price	Change	Country
1	Kuros Biosciences AG 1 KURN.SW	13.53	Jan. 14, 2025	USD 24.15	-4.07%	Switzerland
2	Straumann Holding AG 2 STMN.SW	9.49	Jan. 14, 2025	USD 129.81	2.09%	Switzerland
3	SKAN Group AG 3 SKAN.SW	9.14	Jan. 14, 2025	USD 81.72	-0.97%	Switzerland
4	Ypsomed Holding AG 4 YPSN.SW	7.09	Jan. 14, 2025	USD 355.46	-1.48%	Switzerland
5	Roche Holding AG 5 RO.SW	6.71	Jan. 14, 2025	USD 310.22	0.71%	Switzerland
6	Medacta Group SA 6 MOVE.SW	6.54	Jan. 14, 2025	USD 119.40	0.87%	Switzerland
7	Dätwyler Holding AG 7 DAE.SW	5.21	Jan. 14, 2025	USD 140.65	0.97%	Switzerland
8	Siegfried Holding AG 8 SFZN.SW	4.54	Jan. 14, 2025	USD 1.04 K	-2.38%	Switzerland
9	Novartis AG 9 NOVN.SW	4.23	Jan. 14, 2025	USD 98.71	-0.26%	Switzerland
10	Lonza Group AG 10 LONN.SW	3.78	Jan. 14, 2025	USD 588.68	-0.80%	Switzerland
11	Medartis Holding AG 11 MED.SW	3.30	Jan. 14, 2025	USD 73.39	4.71%	Switzerland
12	Dottikon Es Holding AG 12 DESN.SW	3.23	Jan. 14, 2025	USD 229.49	0.50%	Switzerland
13	COLTENE Holding AG 13 CLTN.SW	2.94	Jan. 14, 2025	USD 56.52	-0.28%	Switzerland
14	Bachem Holding AG 14 BANB.SW	2.92	Jan. 14, 2025	USD 61.01	0.32%	Switzerland
15	Sandoz Group AG 15 SDZ.SW	2.54	Jan. 14, 2025	USD 42.16	0.08%	Switzerland
16	Santhera Pharmaceuticals Holding AG 16 SANN.SW	2.47	Jan. 14, 2025	USD 14.50	8.00%	Switzerland
17	Galenica AG 17 GALE.SW	2.40	Jan. 14, 2025	USD 84.29	1.29%	Switzerland
18	DKSH Holding AG 18 DKSH.SW	2.39	Jan. 14, 2025	USD 73.83	-0.24%	Switzerland
19	IVF Hartmann Holding AG 19 VBSN.SW	2.21	Jan. 14, 2025	USD 165.41	0.50%	Switzerland
20	PolyPeptide Group AG 20 PPGN.SW	2.19	Jan. 14, 2025	USD 27.99	-3.47%	Switzerland
21	Alcon Inc. 21 ALC.SW	1.99	Jan. 14, 2025	USD 82.92	0.05%	Switzerland
22	Tecan Group AG 22 TECN.SW	1.96	Jan. 14, 2025	USD 244.50	0.95%	Switzerland
23	DSM-Firmenich AG 23 DSFIR.AS	1.03	Jan. 14, 2025	USD 97.52	0.29%	Switzerland
24	CPH Chemie + Papier Holding AG 24 CPHN.SW	0.99	Jan. 14, 2025	USD 85.22	-0.53%	Switzerland
25	Molecular Partners AG 25 MOLN.SW	0.96	Jan. 14, 2025	USD 5.48	3.60%	Switzerland
26	Metall Zug AG 26 METN.SW	0.96	Jan. 14, 2025	USD 1.16 K	0.97%	Switzerland
27	medmix AG 27 MEDX.SW	0.82	Jan. 14, 2025	USD 11.09	-3.14%	Switzerland
28	DocMorris AG 28 0RRB.L	0.33	Jan. 14, 2025	USD 19.40	2.88%	Switzerland
29	Basilea Pharmaceutica AG 29 BSLN.SW	-45.43	Jan. 14, 2025	USD 44.53	-0.85%	Switzerland

Frequently Asked Questions

Which Pharmaceuticals company in Switzerland has the highest Price to Book Ratio (P/B) ?

The Pharmaceuticals company in Switzerland with the highest Price to Book Ratio (P/B) is Kuros Biosciences AG (Swiss Stock Exchange: KURN.SW) at 13.53.
Which Pharmaceuticals company in Switzerland has the lowest Price to Book Ratio (P/B) ?

The Pharmaceuticals company in Switzerland with the lowest Price to Book Ratio (P/B) is Basilea Pharmaceutica AG (Swiss Stock Exchange: BSLN.SW) at -45.43.

What are the top 10 Pharmaceuticals companies in Switzerland by Price to Book Ratio (P/B) ?

The top 10 Pharmaceuticals companies in Switzerland by Price to Book Ratio (P/B) are Kuros Biosciences AG, Straumann Holding AG, SKAN Group AG, Ypsomed Holding AG, Roche Holding AG, Medacta Group SA, Dätwyler Holding AG, Siegfried Holding AG, Novartis AG and Lonza Group AG.
What are the bottom 10 Pharmaceuticals companies in Switzerland by Price to Book Ratio (P/B) ?

The bottom 10 Pharmaceuticals companies in Switzerland by Price to Book Ratio (P/B) are Basilea Pharmaceutica AG, DocMorris AG, medmix AG, Metall Zug AG, Molecular Partners AG, CPH Chemie + Papier Holding AG, DSM-Firmenich AG, Tecan Group AG, Alcon Inc. and PolyPeptide Group AG.